CoronaVac
Sinovac vaccine against COVID-19
Press Enter · cited answer in seconds
0 sources
Summary
CoronaVac is a funded product[1].
Key Facts
- Instance of: vaccine[2]
- Manufacturer: Sinovac Biotech[3]
- Developer: Sinovac Biotech[4], Instituto Butantan[5], Bio Farma[6]
- Subclass of: COVID-19 vaccine[7], inactivated vaccine[8]
- Route of administration: intramuscular injection[9]
- Described by source: Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)[10], Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19)[11], Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial[12], Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals[13], A Phase III, Observer-blind, Randomized, Placebo-controlled Study of the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 Years in Indonesia[14]
- Vaccine for: COVID-19[15]
- Funder: Sinovac Biotech[16]